Latest Artia Global Partners LP Stock Portfolio
Artia Global Partners LP Performance:
2024 Q3: 2.62%YTD: 21.17%2023: 1.83%
Performance for 2024 Q3 is 2.62%, and YTD is 21.17%, and 2023 is 1.83%.
About Artia Global Partners LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Artia Global Partners LP reported an equity portfolio of $366.9 Millions as of 30 Sep, 2024.
The top stock holdings of Artia Global Partners LP are , LLY, VKTX. The fund has invested 24.1% of it's portfolio in NOVO-NORDISK A S and 22.4% of portfolio in ELI LILLY & CO.
The fund managers got completely rid off MERCK & CO INC (MRK), OCULAR THERAPEUTIX INC (OCUL) and APOGEE THERAPEUTICS INC stocks. They significantly reduced their stock positions in IONIS PHARMACEUTICALS INC (IONS), CRINETICS PHARMACEUTICALS IN (CRNX) and CHARLES RIV LABS INTL INC (CRL). Artia Global Partners LP opened new stock positions in REVOLUTION MEDICINES INC (RVMD), NUVALENT INC (NUVL) and CENTESSA PHARMACEUTICALS PLC (CNTA). The fund showed a lot of confidence in some stocks as they added substantially to SOLENO THERAPEUTICS INC (SLNO), CORBUS PHARMACEUTICALS HLDGS (CRBP) and MERUS N V (MRUS).
The top stock holdings of Artia Global Partners LP are , LLY, VKTX. The fund has invested 24.1% of it's portfolio in NOVO-NORDISK A S and 22.4% of portfolio in ELI LILLY & CO.
The fund managers got completely rid off MERCK & CO INC (MRK), OCULAR THERAPEUTIX INC (OCUL) and APOGEE THERAPEUTICS INC stocks. They significantly reduced their stock positions in IONIS PHARMACEUTICALS INC (IONS), CRINETICS PHARMACEUTICALS IN (CRNX) and CHARLES RIV LABS INTL INC (CRL). Artia Global Partners LP opened new stock positions in REVOLUTION MEDICINES INC (RVMD), NUVALENT INC (NUVL) and CENTESSA PHARMACEUTICALS PLC (CNTA). The fund showed a lot of confidence in some stocks as they added substantially to SOLENO THERAPEUTICS INC (SLNO), CORBUS PHARMACEUTICALS HLDGS (CRBP) and MERUS N V (MRUS).
Artia Global Partners LP Annual Return Estimates Vs S&P 500
Our best estimate is that Artia Global Partners LP made a return of 2.62% in the last quarter. In trailing 12 months, it's portfolio return was 30.09%.
New Buys
| Ticker | $ Bought |
|---|---|
| revolution medicines inc | 4,348,380 |
| nuvalent inc | 1,579,200 |
| centessa pharmaceuticals plc | 1,285,280 |
| alector inc | 900,857 |
| acelyrin inc | 459,052 |
| summit therapeutics inc | 317,813 |
| q32 bio inc | 209,937 |
New stocks bought by Artia Global Partners LP
Additions
| Ticker | % Inc. |
|---|---|
| soleno therapeutics inc | 190 |
| corbus pharmaceuticals hldgs | 137 |
| merus n v | 59.8 |
| eyepoint pharmaceuticals inc | 53.99 |
| viking therapeutics inc | 17.64 |
| annexon inc | 16.78 |
| ideaya biosciences inc | 15.81 |
| verona pharma plc | 13.61 |
Additions to existing portfolio by Artia Global Partners LP
Reductions
| Ticker | % Reduced |
|---|---|
| ionis pharmaceuticals inc | -51.22 |
| crinetics pharmaceuticals in | -46.64 |
| charles riv labs intl inc | -8.69 |
| insmed inc | -0.93 |
Artia Global Partners LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| ocular therapeutix inc | -3,420,000 |
| merck & co inc | -54,782,000 |
| apogee therapeutics inc | -2,298,040 |
| pliant therapeutics inc | -537,500 |
| sarepta therapeutics inc | -410,800 |
Artia Global Partners LP got rid off the above stocks
Sector Distribution
Artia Global Partners LP has about 67.5% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 67.5 |
| Others | 32.5 |
Market Cap. Distribution
Artia Global Partners LP has about 31.3% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 33.2 |
| MID-CAP | 28.9 |
| MEGA-CAP | 23.2 |
| LARGE-CAP | 8.1 |
| SMALL-CAP | 6.6 |
Stocks belong to which Index?
About 54.9% of the stocks held by Artia Global Partners LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 45.1 |
| RUSSELL 2000 | 28.9 |
| S&P 500 | 26 |
Artia Global Partners LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Artia Global Partners LP
Artia Global Partners LP has 44 stocks in it's portfolio. About 77.4% of the portfolio is in top 10 stocks. LLY proved to be the most loss making stock for the portfolio. VKTX was the most profitable stock for Artia Global Partners LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALEC | alector inc | 0.25 | 193,317 | 900,857 | new | |||
| ALNY | alnylam pharmaceuticals inc | 2.62 | 35,000 | 9,626,050 | unchanged | 0.00 | ||
| ANNX | annexon inc | 0.28 | 172,226 | 1,019,580 | added | 16.78 | ||
| AXSM | axsome therapeutics inc | 2.15 | 87,848 | 7,894,900 | unchanged | 0.00 | ||
| CLDX | celldex therapeutics inc new | 0.70 | 75,300 | 2,559,450 | unchanged | 0.00 | ||
| CNTA | centessa pharmaceuticals plc | 0.35 | 80,380 | 1,285,280 | new | |||
| CRBP | corbus pharmaceuticals hldgs | 0.27 | 47,400 | 977,862 | added | 137 | ||
| CRL | charles riv labs intl inc | 0.34 | 6,305 | 1,241,900 | reduced | -8.69 | ||
| CRNX | crinetics pharmaceuticals in | 0.64 | 45,765 | 2,338,590 | reduced | -46.64 | ||
| DYN | dyne therapeutics inc | 1.17 | 119,488 | 4,292,010 | unchanged | 0.00 | ||
| EYPT | eyepoint pharmaceuticals inc | 0.34 | 156,300 | 1,248,840 | added | 53.99 | ||
| IDYA | ideaya biosciences inc | 0.54 | 62,992 | 1,995,590 | added | 15.81 | ||
| INSM | insmed inc | 1.05 | 52,939 | 3,864,550 | reduced | -0.93 | ||
| IONS | ionis pharmaceuticals inc | 0.33 | 30,479 | 1,220,990 | reduced | -51.22 | ||
| ITCI | intra-cellular therapies inc | 4.32 | 216,519 | 15,842,700 | unchanged | 0.00 | ||
| KROS | keros therapeutics inc | 0.32 | 20,000 | 1,161,400 | unchanged | 0.00 | ||
| KURA | kura oncology inc | 0.30 | 57,178 | 1,117,260 | unchanged | 0.00 | ||
| LLY | eli lilly & co | 22.36 | 92,593 | 82,031,800 | unchanged | 0.00 | ||
| LRMR | larimar therapeutics inc | 0.16 | 90,490 | 592,710 | unchanged | 0.00 | ||
| MDGL | madrigal pharmaceuticals inc | 0.09 | 1,557 | 330,427 | unchanged | 0.00 | ||